Alexandria University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Alexandria Egypt (1938)

Organization Overview

First Clinical Trial
2003
NCT00340379
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Alexandra University Hospital, Athens - GREECE | Alexandria Faculty of Medicine | Alexandria Univeristy | AlexandriaUniversity | Alexandria University | Alexandria university, Faculty of dentistry | Alexandria University, Faculty of Dentistry | Alexandria University Faculty of Medicine | Alexandria University, Faculty of Medicine | Alexandria University Hospitals | Alexandria Univsersity | Alrxandria university | Assistant lecturer | Assistant Professor of Oncology, Faculty of Medicine, Alexandria University | Assoc. Prof. Ayman Baeis | Ass. Professor of Critical Care Medicine, Alexandria University. | Aya Sakr | Basma Morsy | cardiologist , alexandria university | Department of neurosurgery, faculty of medicine , Alexandria university | Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt | Department of Tropical Medicine & Infectious Diseases, Alexandria University | Dina Youssef Attia | Dr. Noha Alaa Eldine Hassan Hamdy | Faculty of dentistry, Alexandria University, Alexandria, Egypt. | Faculty of Dentistry, Alexandria University, Egypt | Faculty of Dentistry, Alexandria University, Egypt and College of Dentistry, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia | Faculty of Medicine, Alexandria Univerity | Faculty of Medicine, Alexandria University - Alexandria | Faculty of Medicine, Alexandria University, Alexandria Governorate, Egypt. | Faculty of Medicine, Alexandria University, Egypt | Faculty of Medicine, University of Alexandria | Faculty of Nursing, Alexandria University | Faculty of Pharmacy, Alexandria University | Faculty of Pharmacy, Alexandria University, Egypt | Gamal Mohamed Taha Abouelmagd | Hams Hamed Abdelrahman | High Institute of Public Health, Alexandria University | Jaylane kadry Ghonima | lecturer | Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university | Lecturer of Internal Medicine and Hepatology, Faculty of Medicine, Alexandria University | Lecturer of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University | Maha Talaab | Marwa Mohamed Farag | Medical Biochemistry and Molecular Biology department. Faculty of Dentistry, Alexandria University, Alexandria, Egypt. | Mohamed Hayder Oleish Salih | Mohammed samir | Neuropsychiatry department, Faculty of Medicine, Alexandria University | Nourhan M.Aly | otorhinolaryngology department, Faculty of Medicine, Alexandria University | Otorhinolaryngology department, Faculty of Medicine, Alexandria University | Otorhinolaryngology department,Faculty of Medicine, Alexandria University | periodontology department. Faculty of dentistry. Alexandria university | Pharmaceutics department. Faculty of Pharmacy, Alexandria University; Alexandria, Egypt. | Ph. Hanya Hesham Sweilam | private practice, Alexandria, Egypt | Professor in Pharmacology, Faculty of Pharmacy, Alexandria University | Professor of Critical Care Medicine, Alexandria University. | Professor of Endodontics, Faculty of Dentistry, Alexandria University | Professor of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University | Professor of Pharmacology and Therapeutics, Faculty of Pharmacy Alexandria University | resident of Nephrology & Internal Medicine, Alexandria University Hospitals | Salma Nabil | Sara Zayed | Sherifa Ghaleb | Teaching assistant in Pharmacology, Faculty of Pharmacy, Alexandria University | University of Alexandria | Yousra Hisham Abdel Fattah

Active Ingredients

Drugs in Phase 4 Trials (37)

alteplase (Activase) (1 trial)

amlodipine (norvasc) (1 trial)

amoxicillin (2 trials)

avanafil (stendra) (1 trial)

bisoprolol (zebeta) (3 trials)

bovine lactoferrin (1 trial)

bupivacaine (Exparel) (6 trials)

clarithromycin (biaxin) (2 trials)

daclatasvir (daklinza) (2 trials)

dextrose (5 trials)

duloxetine (Cymbalta) (3 trials)

empagliflozin (jardiance) (1 trial)

esomeprazole (nexium) (1 trial)

estradiol (progynon depot) (2 trials)

fentanyl (Innovar) (4 trials)

follitropin alfa (Gonal-F) (1 trial)

gabapentin (neurontin) (1 trial)

growth hormone (Protropin) (1 trial)

ivabradine (corlanor) (2 trials)

ledipasvir (Harvoni) (1 trial)

lemongrass oil (2 trials)

linagliptin (tradjenta) (1 trial)

Menotropin (Menopur) (2 trials)

metformin (glucophage) (4 trials)

methotrexate (1 trial)

metronidazole (flagyl) (2 trials)

misoprostol (cytotec) (1 trial)

neostigmine (bloxiverz) (2 trials)

onabotulinumtoxinA (Botox) (4 trials)

platelet-rich plasma (3 trials)

prednisone (meticorten) (1 trial)

progesterone (progestasert) (2 trials)

ribavirin (virazole) (2 trials)

sofosbuvir (sovaldi) (3 trials)

triptorelin (Trelstar) (2 trials)

velpatasvir (Epclusa) (1 trial)

vonoprazan (Voquezna) (1 trial)

Drugs in Phase 3 Trials (31)

abobotulinumtoxinA (Dysport) (1 trial)

bisacodyl (Halflytely) (1 trial)

chromium (1 trial)

cyclosporine (sandimmune) (2 trials)

dexmedetomidine (precedex) (6 trials)

haloperidol (haldol) (1 trial)

imatinib (gleevec) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

lactose (1 trial)

lactulose (cephulac) (1 trial)

lubiprostone (amitiza) (1 trial)

lycopene (1 trial)

magnesium sulfate (Tis-U-Sol) (2 trials)

morphine (1 trial)

nitazoxanide (Alinia) (6 trials)

omega-3 fatty acids (Omacor) (1 trial)

panthenol (2 trials)

prednisolone (hydeltra) (1 trial)

propofol (diprivan) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

rosuvastatin (crestor) (2 trials)

sertraline (zoloft) (1 trial)

sevoflurane (ultane) (2 trials)

silver diammine fluoride (6 trials)

silver fluoride (2 trials)

silymarin (1 trial)

sodium picosulfate (Preopik) (1 trial)

spironolactone (aldactone) (1 trial)

tafluprost (zioptan) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 2 Trials (33)

atorvastatin (lipitor) (1 trial)

benzocaine (Orajel) (5 trials)

benzydamine (3 trials)

capecitabine (xeloda) (1 trial)

casein phosphopeptide amorphous calcium phosphate (3 trials)

Cetalkonium (3 trials)

cetylpyridinium chloride (3 trials)

chamomile (1 trial)

chlorhexidine (hibitane) (1 trial)

concentrated growth factor (1 trial)

cyclophosphamide (cytoxan) (1 trial)

darbepoetin alfa (aranesp) (1 trial)

doxorubicin (Doxil) (1 trial)

epoetin (Epogen) (1 trial)

istaroxime (1 trial)

levocarnitine (carnitor) (1 trial)

melatonin (3 trials)

miconazole (monistat) (4 trials)

midazolam (versed) (2 trials)

naltrexone (revia) (2 trials)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (1 trial)

platelet rich fibrin (3 trials)

pregabalin (lyrica) (2 trials)

propolis (1 trial)

remifentanil (ultiva) (1 trial)

rifaximin (xifaxan) (1 trial)

sodium bicarbonate (2 trials)

sodium chloride (3 trials)

sodium fluoride (18F) (2 trials)

triamcinolone (kenalog) (4 trials)

vitamin c (2 trials)

vitamin d3 (6 trials)

Drugs in Phase 1 Trials (5)

dexamethasone (1 trial)

hyaluronic acid (2 trials)

methylprednisolone (medrol) (2 trials)

orochem (1 trial)

povidone-iodine (betadine) (1 trial)

Drugs in Other Trials (27)

acacia (1 trial)

aflibercept (zaltrap) (2 trials)

aloe vera (1 trial)

arachidonic acid (1 trial)

benoxinate (1 trial)

chitosan (1 trial)

colloidal silver (1 trial)

cyanoacrylate (1 trial)

essential oils (1 trial)

ketorolac (acuvail) (1 trial)

levobupivacaine (chirocaine) (1 trial)

l-glutamine (1 trial)

lidocaine (xylocaine) (2 trials)

malic acid (1 trial)

mepivacaine (carbocaine) (1 trial)

methylene blue (proveblue) (1 trial)

milnacipran (savella) (1 trial)

oxygen (1 trial)

oxytocin (syntocinon) (1 trial)

praziquantel (biltricide) (1 trial)

propranolol (inderal) (1 trial)

rebamipide (1 trial)

ropivacaine (naropin) (1 trial)

self-assembling peptide p11-4 (1 trial)

sitagliptin (januvia) (1 trial)

sugammadex (bridion) (1 trial)

trospium (sanctura) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Alopecia (Phase 2)

Alopecia Areata (Phase 2)

Amebiasis (Phase 3)

Atrophy (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Chronic Pain (Phase 3)

Craniofacial Abnormalities (Phase 2)

Dental Caries (Phase 3)

Dental Pulp Necrosis (Phase 2)

Dentin, Secondary (Phase 3)

Depression (Phase 3)

Diabetic Foot (Phase 3)

Disease (Phase 2)

Dysentery, Amebic (Phase 3)

Erectile Dysfunction (Phase 4)

Foot Ulcer (Phase 3)

Glaucoma (Phase 3)

Heart Failure (Phase 4)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 3)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 3)

Hepatitis, Chronic (Phase 3)

Hepatitis E (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Hypertension, Renal (Phase 4)

Infections (Phase 2)

Inflammation (Phase 2)

Insulin Resistance (Phase 4)

Joint Diseases (Phase 2)

Kidney Failure, Chronic (Phase 4)

Knee Injuries (Phase 4)

Labor Pain (Phase 2)

Lichen Planus (Phase 3)

Lichen Planus, Oral (Phase 3)

Lung Injury (Phase 2)

Mental Disorders (Phase 3)

Mood Disorders (Phase 3)

Mucositis (Phase 2)

Necrosis (Phase 2)

Neuralgia (Phase 3)

Optic Atrophy (Phase 2)

Optic Nerve Diseases (Phase 2)

Optic Nerve Injuries (Phase 2)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pain, Postoperative (Phase 4)

Periodontitis (Phase 2)

Pneumonia (Phase 3)

Postpartum Hemorrhage (Phase 4)

Pruritus (Phase 2)

Psychotic Disorders (Phase 3)

Recurrence (Phase 4)

Respiratory Distress Syndrome (Phase 2)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Systemic (Phase 3)

Sclerosis (Phase 3)

Stomatitis (Phase 2)

Temporomandibular Joint Disorders (Phase 2)

Temporomandibular Joint Dysfunction Syndrome (Phase 2)

Thrombosis (Phase 2)

Transfusion-Related Acute Lung Injury (Phase 2)

Ulcer (Phase 3)

Vitiligo (Phase 1)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 143
  • # of Trial APIs: 133